Literature DB >> 3109991

The polyol pathway and glucose 6-phosphate in human endothelial cells cultured in high glucose concentrations.

M Lorenzi, S Toledo, G R Boss, M J Lane, D F Montisano.   

Abstract

In an attempt to identify the mechanisms underlying the ill effects of high glucose previously described in cultured human endothelial cells, we have investigated in these cells the activity of the polyol pathway and accumulation of glucose 6-phosphate, a powerful agent of non-enzymatic glycosylation. Sorbitol accumulation varied among different batches of cells (primary cultures). In presence of 5 mmol/l glucose the cellular sorbitol content ranged from 0.04 to 0.12 nmol/10(6) cells. When cells were exposed to 20 mmol/l glucose the sorbitol content increased by 2- to 3-fold to concentrations of 0.08-0.38 nmol/10(6) cells (p less than 0.01). Addition to the culture medium of 100 mumol/l Sorbinil, an inhibitor of aldose reductase, resulted in a substantial inhibition of sorbitol accumulation throughout the 14 days in culture, but the degree of inhibition varied inversely with the duration of cell exposure to high glucose (70% inhibition in cells exposed to high glucose and Sorbinil for 1-3 days versus 14% inhibition in cells exposed for 14 days, p less than 0.01). Sorbinil treatment failed to improve even slightly the abnormalities in cellular replication induced by high glucose. The cellular content of glucose 6-phosphate was augmented 3-fold by exposure to 20 mmol/l glucose (p less than 0.001). In conjunction with other studies these results indicate that in this model the polyol pathway is not an osmotically or metabolically important mechanism of glucotoxicity, and that the inhibitory activity of Sorbinil on the polyol pathway of human tissues may be a function of their length of exposure to hyperglycaemia. The consequences of intracellular accumulation of glucose 6-phosphate await investigations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3109991     DOI: 10.1007/bf00270419

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  34 in total

Review 1.  The sorbitol pathway and the complications of diabetes.

Authors:  K H Gabbay
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

2.  Renal hypertrophy in experimental diabetes. Changes in pentose phosphate pathway activity.

Authors:  K A Steer; M Sochor; P McLean
Journal:  Diabetes       Date:  1985-05       Impact factor: 9.461

3.  Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasmin.

Authors:  M Brownlee; H Vlassara; A Cerami
Journal:  Diabetes       Date:  1983-07       Impact factor: 9.461

4.  Sequence specific damage of DNA induced by reducing sugars.

Authors:  J Morita; K Ueda; S Nanjo; T Komano
Journal:  Nucleic Acids Res       Date:  1985-01-25       Impact factor: 16.971

Review 5.  Nonenzymatic glycosylation and the pathogenesis of diabetic complications.

Authors:  M Brownlee; H Vlassara; A Cerami
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

6.  Metabolic alterations in the human erythrocyte produced by increases in glucose concentration. The role of the polyol pathway.

Authors:  S F Travis; A D Morrison; R S Clements; A I Winegrad; F A Oski
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

7.  Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity.

Authors:  D A Greene; S A Lattimer
Journal:  Diabetes       Date:  1984-08       Impact factor: 9.461

8.  High glucose concentrations partially release hexokinase from inhibition by glucose 6-phosphate.

Authors:  S Fujii; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

9.  Studies on the permeability of the blood-brain barrier in experimental diabetes.

Authors:  M Lorenzi; D P Healy; R Hawkins; J M Printz; M P Printz
Journal:  Diabetologia       Date:  1986-01       Impact factor: 10.122

10.  Diabetic cataract formation: potential role of glycosylation of lens crystallins.

Authors:  V J Stevens; C A Rouzer; V M Monnier; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

View more
  6 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart.

Authors:  S Srivastava; A Chandra; L F Wang; W E Seifert; B B DaGue; N H Ansari; S K Srivastava; A Bhatnagar
Journal:  J Biol Chem       Date:  1998-05-01       Impact factor: 5.157

Review 3.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

4.  Abnormal glutathione metabolism and increased cytotoxicity caused by H2O2 in human umbilical vein endothelial cells cultured in high glucose medium.

Authors:  A Kashiwagi; T Asahina; M Ikebuchi; Y Tanaka; Y Takagi; Y Nishio; R Kikkawa; Y Shigeta
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

5.  Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats.

Authors:  G Suárez; R Rajaram; K C Bhuyan; A L Oronsky; J A Goidl
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

6.  The effect of high glucose on polyol pathway activity and myoinositol metabolism in cultured human endothelial cells.

Authors:  G C Hawthorne; K Bartlett; C S Hetherington; K G Alberti
Journal:  Diabetologia       Date:  1989-03       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.